| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMEA | Biomea Fusion, Inc. | Valle Franco | Chief Financial Officer | Nov 30, 2023 | Option Exercise | $3.78 | 1,345 | 5,087 | 25,543 | Dec 01, 2023, 05:58 PM | |
| BMEA | Biomea Fusion, Inc. | Valle Franco | Chief Financial Officer | May 31, 2023 | Option Exercise | $3.78 | 4,273 | 16,163 | 24,198 | Jun 02, 2023, 05:01 PM | |
| BMEA | Biomea Fusion, Inc. | Valle Franco | Chief Financial Officer | Nov 30, 2022 | Option Exercise | $3.78 | 2,518 | 9,524 | 19,925 | Dec 02, 2022, 04:30 PM | |
| BMEA | Biomea Fusion, Inc. | Valle Franco | Chief Financial Officer | Nov 11, 2022 | Buy | $7.63 | 4,100 | 31,286 | 17,407 | Nov 14, 2022, 04:30 PM | |
| BMEA | Biomea Fusion, Inc. | Valle Franco | Chief Financial Officer | May 31, 2022 | Option Exercise | $4.67 | 3,307 | 15,432 | 13,307 | Jun 01, 2022, 06:00 PM | |
| BMEA | Biomea Fusion, Inc. | Valle Franco | Chief Financial Officer | Jan 14, 2022 | Buy | $8.68 | 10,000 | 86,767 | 10,000 | Jan 18, 2022, 07:00 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Jan 11, 2021 | Option Exercise | $7.24 | 1,500 | 10,860 | 1,500 | Jan 13, 2021, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Jan 11, 2021 | Sale | $125.61 | 1,500 | 188,408 | 0 | Jan 13, 2021, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Jan 12, 2021 | Option Exercise | $7.24 | 1,747 | 12,648 | 1,747 | Jan 13, 2021, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Jan 12, 2021 | Sale | $125.44 | 1,747 | 219,152 | 0 | Jan 13, 2021, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Nov 09, 2020 | Option Exercise | $7.24 | 1,623 | 11,751 | 1,623 | Nov 10, 2020, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Nov 09, 2020 | Sale | $74.93 | 1,623 | 121,609 | 0 | Nov 10, 2020, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Oct 07, 2020 | Sale | $75.08 | 5,444 | 408,748 | 0 | Oct 09, 2020, 05:23 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Oct 08, 2020 | Option Exercise | $7.24 | 5,199 | 37,641 | 5,199 | Oct 09, 2020, 05:23 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Oct 08, 2020 | Sale | $74.85 | 5,199 | 389,151 | 0 | Oct 09, 2020, 05:23 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Oct 07, 2020 | Option Exercise | $7.24 | 5,000 | 36,200 | 5,444 | Oct 09, 2020, 05:23 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | May 31, 2020 | Option Exercise | $41.57 | 444 | 18,459 | 444 | Jun 05, 2020, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Apr 20, 2020 | Option Exercise | $7.24 | 2,000 | 14,480 | 2,000 | Apr 22, 2020, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Apr 20, 2020 | Sale | $49.79 | 2,000 | 99,580 | 0 | Apr 22, 2020, 04:05 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Mar 26, 2020 | Option Exercise | $7.24 | 5,000 | 36,200 | 5,000 | Mar 30, 2020, 04:23 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Mar 26, 2020 | Sale | $48.26 | 5,000 | 241,310 | 2,000 | Mar 30, 2020, 04:23 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Mar 02, 2020 | Option Exercise | $7.24 | 3,000 | 21,720 | 3,000 | Mar 04, 2020, 04:08 PM | |
| EIDX | Eidos Therapeutics, Inc. | Valle Franco | Senior Vice President, Finance | Mar 02, 2020 | Sale | $52.33 | 3,000 | 156,980 | 1,000 | Mar 04, 2020, 04:08 PM |
Menu